Previous close | 1.2900 |
Open | 1.2900 |
Bid | 0.3500 |
Ask | 3.1000 |
Strike | 175.00 |
Expiry date | 2025-01-17 |
Day's range | 1.2900 - 1.2900 |
Contract range | N/A |
Volume | |
Open interest | 679 |
BD's robust product portfolio and a few strategic deals raise optimism about the stock. However, stiff competition and macroeconomic volatility are concerns.
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has reached an agreement to resolve the vast majority of its existing hernia litigation.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.